Showing 1,098 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

Grazoprevir triple regimen demonstrates high cure rates, even for hard-to-treat people

News
25 November 2016
Hepatitis C treatment

People with HIV/HCV co-infection see good cure rates in real-world practice in Madrid

News
23 November 2016
Hepatitis C treatment

8-week triple DAA combo cures most people with genotype 1-6 hepatitis C

News
21 November 2016
Hepatitis C treatment

AbbVie pangenotypic combination cures 98% or above across genotypes

News
16 November 2016
Hepatitis C treatment

AbbVie pangenotypic combination cures almost all hard-to-treat people with HCV genotype 3

News
16 November 2016
Hepatitis C treatment

US Veterans Affairs and Australia show potential for rapid elimination of hepatitis C

News
15 November 2016
Hepatitis C treatment

Grazoprevir/elbasvir + sofosbuvir highly effective for hard-to-treat genotype 3 hepatitis C patients

News
14 November 2016
Access to healthcare

Where hepatitis C rates are seven times the US average — and a cure is kept out of reach

Editor's pick
STAT
14 November 2016
Hepatitis C treatment

Liver cancer risk reduced after hepatitis C treatment, but vigilance needed for aggressive cancers in months after treatment

News
14 November 2016
Hepatitis C treatment

Real-world responses to HCV treatment among US veterans match best clinical trial results

News
14 November 2016
Access to healthcare

These researchers think they have a solution to the global crisis in drug prices

Editor's pick
Washington Post
8 November 2016
Access to healthcare

Buyers clubs for cheaper drugs help fight hepatitis and HIV

Editor's pick
Reuters
7 November 2016
Hepatitis C treatment

The Cost Of A Cure: Revisiting Medicare Part D And Hepatitis C Drugs

Editor's pick
Health Affairs (blog)
4 November 2016
Pharmaceutical industry

Gilead sales of Hepatitis C drugs slump

Editor's pick
MarketWatch
2 November 2016
Access to healthcare

Over 1 million treated with highly effective hepatitis C medicines

Editor's pick
World Health Organization
27 October 2016
Hepatitis C treatment

Generic hepatitis C drugs purchased online achieve high cure rates

News
27 October 2016
Access to healthcare

New $90-$90-$90 target needed for global viral hepatitis, HIV and TB treatment

News
24 October 2016
Hepatitis C treatment

A promising Hep C program seems to be working — and it could be a model for other countries

Editor's pick
Business Insider
24 October 2016
Hepatitis C treatment

Eliminating hepatitis C as a major public health threat needs a two-pronged attack

Editor's pick
Public Health England
18 October 2016
Hepatitis C treatment

Punjab hepatitis control programme on verge of collapse

Editor's pick
Daily Times
18 October 2016
Hepatitis C treatment

People infected by hepatitis C in Canada have limited access to direct-acting antivirals

Editor's pick
CRCHUM Montreal
17 October 2016
Hepatitis B

Hepatitis B testing should be done before hepatitis C treatment due to risk of HBV reactivation

News
7 October 2016
Pharmaceutical industry

European regulator amends some Gilead hep C patent claims

Editor's pick
STAT
6 October 2016
Hepatitis C treatment

HCV Drugs May Reactivate HBV, FDA Warns

Editor's pick
Medscape (free registration required)
6 October 2016